Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
Top Cited Papers
- 1 June 2004
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 363 (9426), 2015-2021
- https://doi.org/10.1016/s0140-6736(04)16449-0
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Direct Anti-Inflammatory Mechanisms Contribute to Attenuation of Experimental Allograft Arteriosclerosis by StatinsCirculation, 2003
- Interaction of Oxidative Stress and Inflammatory Response in Coronary Plaque InstabilityArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Extracellular signal-regulated kinase inhibition by statins inhibits neutrophil activation by ANCAKidney International, 2003
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune diseaseNature, 2002
- Protective Effect of HMG-CoA Reductase Inhibitor on Experimental Renal Ischemia-Reperfusion InjuryAmerican Journal of Nephrology, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?Annual Review of Immunology, 2001
- Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?Atherosclerosis, 2000
- Factors predicting response to treatment in rheumatoid arthritis: The importance of disease durationArthritis & Rheumatism, 2000
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995